Cargando…

Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis

INTRODUCTION: Diabetic ketoacidosis (DKA) is associated with inflammation and increased lipolysis. The macrophage activation marker, soluble CD163 (sCD163), is associated with obesity, non‐alcoholic fatty liver disease and type 2 diabetes. We aimed to investigate whether sCD163 correlates with key e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svart, Mads, Rittig, Nikolaj, Møller, Niels, Møller, Holger J, Gronbaek, Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319477/ https://www.ncbi.nlm.nih.gov/pubmed/29802679 http://dx.doi.org/10.1111/jdi.12869

Ejemplares similares

Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial
por: Rittig, Nikolaj, et al.
Publicado: (2017)

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
por: Ørntoft, Nikolaj Worm, et al.
Publicado: (2021)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
por: Nielsen, Marlene Christina, et al.
Publicado: (2020)

Rare Presentations of Ketoacidosis: Diabetic Ketoalkalosis and Ketoacidosis Secondary to Fasting and Muscular Dystrophy
por: Svart, Mads Vandsted, et al.
Publicado: (2015)

The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis
por: Bossen, Lars, et al.
Publicado: (2023)

Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response
por: Bach, Ermina, et al.
Publicado: (2019)

Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass
por: Kazankov, Konstantin, et al.
Publicado: (2022)

Local production of soluble CD163 in the spondyloarthropathic joint
por: Baeten, D, et al.
Publicado: (2003)

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
por: Kimer, Nina, et al.
Publicado: (2018)

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease
por: Glavind, Emilie, et al.
Publicado: (2020)

A New Serum Macrophage Checkpoint Biomarker for Innate Immunotherapy: Soluble Signal-Regulatory Protein Alpha (sSIRPα)
por: Vladimirova, Yoanna V., et al.
Publicado: (2022)

Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
por: Stilund, Morten, et al.
Publicado: (2014)

Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients
por: Kjærgaard, Anders G., et al.
Publicado: (2014)

Soluble haemoglobin scavenger receptor (sCD163): a marker associated with bacteraemia
por: Gaïni, S, et al.
Publicado: (2005)

Hypokalemic Paresis in a 26-Year-Old Man After Recreational Cannabis Use
por: Simonsen, Simon Kjær, et al.
Publicado: (2022)

Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus
por: Sørensen, Lars Peter, et al.
Publicado: (2015)

Investigating effects of sodium beta‐hydroxybutyrate on metabolism in placebo‐controlled, bilaterally infused human leg with focus on skeletal muscle protein dynamics
por: Thomsen, Henrik Holm, et al.
Publicado: (2022)

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021)

Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes
por: Svendsen, Pia, et al.
Publicado: (2016)

Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
por: Nissen, Sara Konstantin, et al.
Publicado: (2020)

Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case–control study
por: Knudsen, Andreas, et al.
Publicado: (2013)

Soluble CD163-Associated Dietary Patterns and the Risk of Metabolic Syndrome
por: Hu, Tzu-Yu, et al.
Publicado: (2019)

Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)

CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood
por: Krijgsman, Daniëlle, et al.
Publicado: (2020)

LPS infusion suppresses serum FGF21 levels in healthy adult volunteers
por: Lauritzen, Esben S, et al.
Publicado: (2017)

Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel
por: Stilund, Morten, et al.
Publicado: (2015)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss
por: Xie, Peilin, et al.
Publicado: (2022)

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
por: Frantz, Camelia, et al.
Publicado: (2018)

Soluble CD163 in intracerebral hemorrhage: biomarker for perihematomal edema
por: Roy‐O'Reilly, Meaghan, et al.
Publicado: (2017)

Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer
por: Lim, Ratana, et al.
Publicado: (2013)

A model mimicking catabolic inflammatory disease; a controlled randomized study in humans
por: Mose, Maike, et al.
Publicado: (2020)

Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis
por: Glavind, Emilie, et al.
Publicado: (2016)

Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liver
por: Møller, Lin Nanna Okholm, et al.
Publicado: (2015)

Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease
por: Azuma, Yoshihiro, et al.
Publicado: (2020)

Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis
por: Zhang, Yue, et al.
Publicado: (2021)

Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2023)

The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids
por: Thomsen, Henrik H, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mj7v4g5huub5t824jmclto5q4b